Found 10 matching trials
A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers PHASE1 This study is a multi-center, double-blind, placebo-controlled, Phase I stu...
Show More Location
University of Iowa - Vaccine Research and Education Unit
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Metastatic Solid Tumors PHASE1 This phase I trial studies the side effects and best dose of vaccine therap...
Show More Location
Ohio State University Medical Center
Learn More & Join Trial
Phase 1 Study of the Safety, Reactogenicity, and Immunogenicity of AMA1-C1/ISA 720: Blood Stage Vaccine for Plasmodium Falciparum PHASE1 This study will evaluate the safety and effectiveness of a vaccine called A...
Show More Location
QIMR - CLive Berghofer Cancer Research Centre
Learn More & Join Trial
Safety and Efficacy Study of Plasmodium Falciparum LSA-3 Malaria Vaccine PHASE1 Malaria is responsible for over 2 million deaths each year. The development...
Show More Location
Radboud University Nijmegen Medical Centre
Learn More & Join Trial
Trial to Assess the Efficacy of Malaria Vaccine PfCS 102 PHASE1 Phase I/IIa double-blind randomized (adjuvant)-controlled trial. 16 volunte...
Show More Location
Department of Ambulatory Care and Community Medicine; University Hospital
Learn More & Join Trial
A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer PHASE1 An Open Label, Multi-Center, Dose Escalation/Expansion, Phase 1/1b Study of...
Show More Learn More & Join Trial
CpG 7909/Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein for NY-ESO-1-expressing Tumors PHASE1 Subjects will receive immunizations every other week for 8 immunizations pr...
Show More Location
Hillman Cancer Center
Learn More & Join Trial
Assessment of Three Formulations of the Candidate Vaccine AMA 1 in Healthy Dutch Adult Volunteers PHASE1 The objective of this study was to evaluate the safety of a candidate malar...
Show More Location
Radboud University Nijmegen Medical Centre
Learn More & Join Trial
A Study of Safety and Immunogenicity of a Malaria Vaccine Candidate PHASE1 Shanghai Wanxing Bio-Pharmaceuticals is currently evaluating one malaria va...
Show More Location
Shanghai Changhai Hospital
Learn More & Join Trial
Safety and Immunogenicity Study of Plasmodium Vivax CS Derived Synthetic Peptides Formulated in Two Adjuvants PHASE1 This was a phase I double blind controlled vaccine trial, evaluating safety...
Show More Location
Malaria Vaccine and Drug Testing Center
Learn More & Join Trial